{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-23-000871","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2023-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.410964+00:00","generated_at":"2026-06-11T08:05:45.959927+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Blue Shield of California to drop CVS Caremark as PBM except specialty; CVS reaffirms 2023 guidance","bullets":["Blue Shield of California will use multiple pharmacy providers starting 2024; CVS Caremark retained only for specialty pharmacy.","Partial contract termination has no impact on CVS's 2023 guidance and immaterial longer-term impact.","CVS reaffirms 2023 GAAP diluted EPS range $6.53-$6.75, adjusted EPS $8.50-$8.70, cash flow from ops $12.5B-$13.5B.","CVS states CVS Caremark remains the leading U.S. PBM by members and health plans served."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-23-000871","json":"https://secwatch.observer/filing/0000947871-23-000871.json","markdown":"https://secwatch.observer/filing/0000947871-23-000871.md","text":"https://secwatch.observer/filing/0000947871-23-000871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000871/0000947871-23-000871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000871/ss2400841_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T08:05:45.959927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}